the Pathophysiology of COVID-19 infection, it's main ways of transmission, Viral loading and shedding, symptoms in addition to it's occupational hazards and it's precautions.
2. AT THE END OF THIS LECTURE YOU WILL BE AWARE OF :
1. Pathophysiology of COVID-19 infection .
2. COVID-19 infection sources .
3. Modes of transmission Of the virus and differentiate between each mode.
4. Acknowledge if COVID-19an airborne transmitted disease or not.
5. COVID-19 Viral loading and shedding
6. Pre-symptomatic transmission of COVID-19.
7. Saliva and salivary glands role in COVID-19 spread.
8. COVID-19 occupational dental hazards.
.
ILOS
5. Nasal and bronchial and pneumocytes are
mostly the target cells.
ACE2 AND TMPRSS2 are the responsible
receptors for COVID-19 BINDING
It’s usually resembling a common cold
pathophysiology
01.Asymptomaticstate
01
02
03
6. - Day 3- 10.
- Active replication of the virus in this
phase is present.
- The patients usually shows signs and
symptoms of fatigue.
-
pathophysiology
02.UPPER AIRWAYRESONCE
01
02
03
7. - >Day 10.
the patient usually shows
lung injury.
- Viral necrosis
pathophysiology
03. Inflammatory state
01
02
03
10. corona virussources
the whole genome
level, the human
nCoV-2019 is 96%
identical to a bat
coronavirus.
they provided a partial
spike gene to COVID-19
and it was also suggested
that the pangolins are a
natural reservoir of the
COVID-19 virus
The resampling
similarity codon
usage bias of COVID-
19 is similar to that
of Bungarus
multicinctus snake
Bats pangolin
Snakes mink
- It’s documented that
mink shows COVID-19
transmission to human
- It also responsible for
the so called FVI-spike
mutation in one strand of
the virus
13. Modes ofINFECTION
02 humantohuman
2A. Horizontal transmission
Direct contact transmission;
- This occur virus transmitted through contaminated
objects or surfaces and infecting people through the
mouth, nose, or eyes.
- Healthcare providers attending with COVID-19
patients are especially at risk of being infected via
this mode of disease transmission.
15. SURFACE TIME
Sprayers 3 hours
Copper 4 hours
Plastic 2-3 days
SURFACE TIME
Cardboard 24 hours
Steel 2-3 days
Wood 4 days
COVID-19INDIFFERENT SURFACES
16. Modes ofINFECTION
02 humantohuman
2A. Horizontal transmission
Droplet transmission;
- droplets that contain the virus from reflective
coughing or sneezing can transmit the disease.
- it’s the most dangerous form of COVID-19 spread
among healthcare providers.
17. Modes ofINFECTION
02 humantohuman
2A. Horizontal transmission
Aerosol transmission;
- Aerosol to mean the small respirable particles
<5–10 μm that can remain airborne and are capable
of short and long range transport.
- The virus remains viable for at least 3 h in aerosols
and 48 -72 h on stainless steel and plastic surfaces.
19. - To date the 1ry concern is near field
transmission.
-
it’snot!
less than 1m
- According to current evidence Among 75,465
COVID-19 cases in china, airborne transmission
was not reported.
20. A although the corona virus is not principally an airborne virus, but;
● Normal breathing, talking droplets are within <1 μm .
● Other environmental factors aren’t considered. Eg; humidity and temperature
● Limited empirical data on aerosolized COVID-19.
It’snot
but…
21. Modes ofINFECTION
02 humantohuman
2A. Horizontal transmission
Fecal-oral transmission;
-gastric glandular, colon, ileum absorptive
enterocytes, duodenal and rectal cells shares
ACE2.
- Clearance of the COVID-19 virus in the respiratory
tract occur within two weeks, whereas the feces can
remain positive for viral RNA for longer than 4 weeks.
23. Modes ofINFECTION
02 humantohuman
2B. Vertical transmission
- there’s high expression of ACE2 receptors in the
human maternal-fetal inter- phase.
- There is low risk for vertical transmission from
Maternal COVID-19.
- breastfeeding is safe for the newborn.
24. viralloadingandshedding
- COVID-19 has a median
incubation period of 3 days
- The median period of viral
release from the time patients
nasopharyngeal swab tested positive, is 12
days.
25. Pre-symptomatic transmission
- COVID-19 infection occurred on average
1.99 and 3.68 days before symptom onset
of the infector.
- There’s at least 65% of transmission
occurring before symptom onset.
(Tindale et al., 2020)
Pre-symptomatic infection as estimated by samples of (serial interval - incubation period), accounting for
covariation. Top: Singapore. Bottom: Tianjin. Left: without intermediates. Right: accounting for
intermediates. Grey vertical line: 0. Samples below zero indicate pre-symptomatic transmission.
In all cases there is substantial pre-symptomatic transmission.
26. ● In majority of cases corona virus genome has been detected in the saliva.
● The highest viral load in COVID-19 patients are in the saliva and the sputum.
● The saliva is a convenient noninvasive sample for the diagnosis of COVID-19.
Doessalivaplayarole
inCOVID-19 SPREAD?
27. ● There’s high expression of the ACE2 receptor was found in minor salivary
glands.
● the source of virus in saliva has not been fully investigated in most studies.
● the salivary glands can be infected but it’s hard to insure that they act as a
reservoir for COVID-19.
Arethesalivaryglandsthekey
playersinCOVID-19spread?
29. 04 05 06
01 02 03
- Aerosols which carry
COVID-19 for over 3 hours.
- Infection through eyes from
splashes and aerosols
Subclinical patients can
spread COVID-19.
- Possibility of COVID-19
inhalation from various
dental procedures.
- Contaminated environment. Direct contact transmission ;
through oral mucosa or
contaminated hand and
possibility of gloves puncture.
Indeed dentalprofessionals athighriskofcontagiondueto;
33. 1. Anderson, E. L., Turnham, P., Griffin, J. R., & Clarke, C. C. (2020). Consideration of the Aerosol Transmission for COVID-19 and Public Health. Risk
Analysis, 40(5), 902–907. https://doi.org/10.1111/risa.13500
2. da Silva Pedrosa, M., Sipert, C. R., & Nogueira, F. N. (2020). Are the salivary glands the key players in spreading COVID-19 asymptomatic infection
in dental practice? Journal of Medical Virology, 1–2. https://doi.org/10.1002/jmv.26316
3. Izzetti, R., Nisi, M., Gabriele, M., & Graziani, F. (2020). COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy.
Journal of Dental Research, 99(9), 1030–1038. https://doi.org/10.1177/0022034520920580
4. Mason, R. J. (2020). Pathogenesis of COVID-19 from a cell biology perspective. European Respiratory Journal, 55(4), 9–11.
https://doi.org/10.1183/13993003.00607-2020
5. Odeh, N. D., Babkair, H., Abu-Hammad, S., Borzangy, S., Abu-Hammad, A., & Abu-Hammad, O. (2020). COVID-19: Present and future challenges for
dental practice. International Journal of Environmental Research and Public Health, 17(9). https://doi.org/10.3390/ijerph17093151
6. Passarelli, P. C., Rella, E., Manicone, P. F., Garcia-Godoy, F., & D’Addona, A. (2020). The impact of the COVID-19 infection in dentistry. Experimental
Biology and Medicine, 245(11), 940–944. https://doi.org/10.1177/1535370220928905
7. Rahman, H. S., Aziz, M. S., Hussein, R. H., Othman, H. H., Salih Omer, S. H., Khalid, E. S., Abdulrahman, N. A., Amin, K., & Abdullah, R. (2020). The
transmission modes and sources of COVID-19: A systematic review. International Journal of Surgery Open, 26(September), 125–136.
https://doi.org/10.1016/j.ijso.2020.08.017
8. Safety, F., & Businesses, F. (2020). COVID-19 and Food Safety: Guidance for food businesses: Interim guidance. COVID-19 and Food Safety:
Guidance for Food Businesses: Interim Guidance, April, 1–6. https://doi.org/10.4060/ca8660en
9. Tindale, L. C., Stockdale, J. E., Coombe, M., Garlock, E. S., Lau, W. Y. V., Saraswat, M., Zhang, L., Chen, D., Wallinga, J., & Colijn, C. (2020). Evidence
for transmission of covid-19 prior to symptom onset. ELife, 9, 1–34. https://doi.org/10.7554/eLife.57149
10. Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020). Pathophysiology, Transmission, Diagnosis, and Treatment of
Coronavirus Disease 2019 (COVID-19): A Review. JAMA - Journal of the American Medical Association, 324(8), 782–793.
https://doi.org/10.1001/jama.2020.12839
References;
SARS-CoV-2 targets cells, such as nasal and bronchial epithelial cells and pneumocytes, through the viral structural spike (S) protein that binds to the angiotensin-converting enzyme 2 (ACE2) receptor. The type 2 transmembrane serine protease (TMPRSS2), present in the host cell, promotes viral uptake by cleaving ACE2 and activating the SARS-CoV-2 S protein, which mediates coronavirus entry into host cells
called the DFVI-spike mutant, has four mu- tations in the gene coding for the spike pro- tein, which helps the virus enter host cells. Experiments with the DFVI strain showed plasma from recovered COVID-19 patients or rabbits immunized with the vi- rus did not neutralize it as efficiently as the unmutated virus.
iologist David Kennedy of Pennsylvania State University, University Park, agrees mutations in the spike protein “could completely undermine” vaccine efficacy, especially if they occur in the part of the protein that binds to the human receptor, as one of the four mutations in DFVI does.
Respiratory air normally contains an abundance of droplets of sizes less than 5 mm in diameter. dan expulsion of droplets from the oral cavity and respiratory tract. In COVID-19 patients these droplets contain a virus that if inhaled or ingested or landing on the mucous membranes will cause disease in people . This mode transmission is the most dangerous form of COVID-19 spread among healthcare providers. The use of PPE with efficient barriers to the droplets and maintenance of personal and environmental hygiene will limit the rate of infections.
To date, primary concern has focused on near- field transmission, particularly protective of coughing and sneezing from infected individuals, and hand-to- face transport from surfaces.
According to current evidence, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. In an analysis of 75,465 COVID-19 cases in China, airborne transmission was not reported Among 75,465 COVID-19 cases in. china, airborne transmission was not reported.
Incidentally, it was shown that there are high expressions of ACE2 in gastric glandular, colon and ileum absorptive enterocytes, duodenal and rectal cells suggesting the virus spread via the fecal-oral route.
Not all neonates of COVID-19-positive mothers acquired the disease because one study showed that none of the neonates born of 31 mothers infected with COVID-19 had the disease
Since the breast milk of COVID-19-mothers is virus-free, breastfeeding is safe for the newborn. However, mothers should be wearing masks during breastfeeding to minimize the risk of transmitting the infection to the newborns through droplets and aerosols. (Rahman et al., 2020)
- The most critical characteristics of a COVID-19 virus are their high capacity for shedding, transmission, and spread.
* Most COVID-19 patients show a high prevalence of the virus in saliva. However, saliva viral load decreases with time. Thus, the saliva is a convenient noninvasive sample for the diagnosis of COVID-19, especially, at the stages of the disease
IT’S suggested SARS‐CoV‐2 coming directly from the salivary gland might be due to high viral loads at the late stage of the disease and not from individuals with mild, limited, or lack of symptoms.
even though the current literature shows that salivary glands can be infected, we cannot affirm that they act as reservoirs for COVID‐19 asymptomatic infections.
Biologic risk of COVID-19 inhalation transmission is extremely high when performing dental procedures due to the use of handpieces under irrigation, which favors the diffusion of aerosol particles of saliva, blood, and secretions.
this production of aerosol facilitates the contamination of the environment and instruments, dental apparatuses, and surfaces.
possibility of gloves puncture but it’s not certain possible to get infected via a glove puncture, but this eventual risk can be notably reduced following the same practices that have been followed by the dental community for the protection from several blood-borne pathogens.